190 related articles for article (PubMed ID: 37795434)
1. Real-world predictors of survival in patients with extensive-stage small-cell lung cancer in Manitoba, Canada: a retrospective cohort study.
Dawe DE; Rittberg R; Syed I; Shanahan MK; Moldaver D; Bucher O; Galloway K; Reynolds K; Paul JT; Harlos C; Kim JO; Banerji S
Front Oncol; 2023; 13():1191855. PubMed ID: 37795434
[TBL] [Abstract][Full Text] [Related]
2. Real-world predictors of survival in patients with limited-stage small-cell lung cancer in Manitoba, Canada.
Dawe DE; Rittberg R; Syed I; Shanahan MK; Moldaver D; Bucher O; Galloway K; Reynolds K; Paul JT; Harlos C; Kim JO; Banerji S
Front Oncol; 2023; 13():1191920. PubMed ID: 38125937
[TBL] [Abstract][Full Text] [Related]
3. Prognostic factor analysis of patients with small cell lung cancer: Real-world data from 988 patients.
Ma X; Zhang Z; Chen X; Zhang J; Nie J; Da L; Hu W; Tian G; Wu D; Han J; Han S; Long J; Wang Y; Fang J
Thorac Cancer; 2021 Jun; 12(12):1841-1850. PubMed ID: 33955685
[TBL] [Abstract][Full Text] [Related]
4. The Real-World Outcome of First Line Atezolizumab in Extensive-Stage Small Cell Lung Cancer: A Multicenter Prospective Cohort Study.
Choi MG; Kim YJ; Lee JC; Ji W; Oh IJ; Lee SY; Yoon SH; Lee SY; Lee JE; Kim EY; Choi CM
Cancer Res Treat; 2024 Apr; 56(2):422-429. PubMed ID: 37871898
[TBL] [Abstract][Full Text] [Related]
5. Prognostic factors for survival in extensive-stage small cell lung cancer: An Italian real-world retrospective analysis of 244 patients treated over the last decade.
Longo V; Pizzutilo P; Catino A; Montrone M; Pesola F; Marerch I; Galetta D
Thorac Cancer; 2022 Dec; 13(24):3486-3495. PubMed ID: 36333988
[TBL] [Abstract][Full Text] [Related]
6. Chemoimmunotherapy in patients with extensive-stage small cell lung cancer and a poor performance status.
Agarwal M; Liu A; Almquist D; Langlais BT; Leventakos K; Yu NY; Manochakian R; Ernani V
Cancer; 2023 Nov; 129(22):3546-3553. PubMed ID: 37548029
[TBL] [Abstract][Full Text] [Related]
7. Real-world eligibility for platinum doublet plus immune checkpoint inhibitors in extensive-stage small-cell lung cancer.
Rittberg R; Leung B; Al-Hashami Z; Ho C
Front Oncol; 2022; 12():1002385. PubMed ID: 36185266
[TBL] [Abstract][Full Text] [Related]
8. Value of pretreatment serum lactate dehydrogenase as a prognostic and predictive factor for small-cell lung cancer patients treated with first-line platinum-containing chemotherapy.
He M; Chi X; Shi X; Sun Y; Yang X; Wang L; Wang B; Li H
Thorac Cancer; 2021 Dec; 12(23):3101-3109. PubMed ID: 34725930
[TBL] [Abstract][Full Text] [Related]
9. Chemoimmunotherapy as the First-Line Treatment for Patients With Extensive-Stage Small-Cell Lung Cancer and an ECOG Performance Status 2 or 3.
Agarwal M; Liu A; Langlais BT; Leventakos K; Yu NY; Almquist D; Manochakian R; Ernani V
Clin Lung Cancer; 2023 Nov; 24(7):591-597. PubMed ID: 37365076
[TBL] [Abstract][Full Text] [Related]
10. Positive Interaction between Prophylactic Cranial Irradiation and Maintenance Sunitinib for Untreated Extensive-Stage Small Cell Lung Cancer Patients After Standard Chemotherapy: A Secondary Analysis of CALGB 30504 (ALLIANCE).
Salama JK; Gu L; Wang X; Pang HH; Bogart JA; Crawford J; Schild SE; Vokes EE; Ready NE
J Thorac Oncol; 2016 Mar; 11(3):361-9. PubMed ID: 26723241
[TBL] [Abstract][Full Text] [Related]
11. Comparison of Carboplatin With Cisplatin in Small Cell Lung Cancer in US Veterans.
Azar I; Yazdanpanah O; Jang H; Austin A; Kim S; Chi J; Alkassis S; Saha BK; Chopra A; Neu K; Mehdi S; Mamdani H
JAMA Netw Open; 2022 Oct; 5(10):e2237699. PubMed ID: 36264573
[TBL] [Abstract][Full Text] [Related]
12. Outcomes of prophylactic cranial irradiation in patients with small cell lung cancer in the modern era of baseline magnetic resonance imaging of the brain.
Held MK; Hansen O; Schytte T; Hansen KH; Bahij R; Nielsen M; Nielsen TB; Jeppesen SS
Acta Oncol; 2022 Feb; 61(2):185-192. PubMed ID: 34583620
[TBL] [Abstract][Full Text] [Related]
13. PIV and PILE Score at Baseline Predict Clinical Outcome of Anti-PD-1/PD-L1 Inhibitor Combined With Chemotherapy in Extensive-Stage Small Cell Lung Cancer Patients.
Zeng R; Liu F; Fang C; Yang J; Luo L; Yue P; Gao B; Dong Y; Xiang Y
Front Immunol; 2021; 12():724443. PubMed ID: 34777341
[TBL] [Abstract][Full Text] [Related]
14. Should Stereotactic Radiosurgery Be Considered for Salvage of Intracranial Recurrence after Prophylactic Cranial Irradiation or Whole Brain Radiotherapy in Small Cell Lung Cancer? A Population-Based Analysis and Literature Review.
Fairchild A; Guest N; Letcher A; Mazure B; Ghosh S; Gabos Z; Chu KP; Debenham B; Nijjar T; Severin D; Scrimger R; Roa W; Yee D
J Med Imaging Radiat Sci; 2020 Mar; 51(1):75-87.e2. PubMed ID: 31759940
[TBL] [Abstract][Full Text] [Related]
15. A retrospective analysis of prognostic factors and treatment choices in small cell lung cancer with liver metastasis.
Zhang S; Wang Y; Li S; Liu Y; Cheng Y
J Thorac Dis; 2023 Dec; 15(12):6776-6787. PubMed ID: 38249882
[TBL] [Abstract][Full Text] [Related]
16. A Multicenter Study Assessing the Real-World Use and Effectiveness of First-Line Chemotherapy Plus Immunotherapy in Advanced Small-Cell Lung Cancer (SCLC) Patients.
Porte M; Vaudron A; Crequit P; Vaugier L; Chatellier T; Fronteau C; Raimbourg J; Goronflot T; Bennouna J; Pons-Tostivint E
Clin Lung Cancer; 2024 Mar; 25(2):e101-e111.e2. PubMed ID: 38072729
[TBL] [Abstract][Full Text] [Related]
17. A retrospective real-world experience of immunotherapy in patients with extensive stage small-cell lung cancer.
Qiu G; Wang F; Xie X; Liu T; Zeng C; Chen Z; Zhou M; Deng H; Yang Y; Lin X; Xie Z; Sun G; Zhou C; Liu M
Cancer Med; 2023 Jul; 12(14):14881-14891. PubMed ID: 37462138
[TBL] [Abstract][Full Text] [Related]
18. Palliative care in poor-performance status small cell lung cancer patients: is there a mandatory role for chemotherapy?
Baldotto CS; Cronemberger EH; de Biasi P; Zamboni M; Sousa A; Zukin M; Small IA; Ferreira CG
Support Care Cancer; 2012 Nov; 20(11):2721-7. PubMed ID: 22322592
[TBL] [Abstract][Full Text] [Related]
19. Prophylactic cranial irradiation in small cell lung cancer: A single institution experience.
Nicholls L; Keir GJ; Murphy MA; Mai T; Lehman M
Asia Pac J Clin Oncol; 2016 Dec; 12(4):415-420. PubMed ID: 27453519
[TBL] [Abstract][Full Text] [Related]
20. Neuron-specific enolase and response to initial therapy are important prognostic factors in patients with small cell lung cancer.
Zhou M; Wang Z; Yao Y; Zhou H; Liu M; Sun J
Clin Transl Oncol; 2017 Jul; 19(7):865-873. PubMed ID: 28127669
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]